Director, Portfolio Strategy

Responsibilities:

• Lead and drive new indication strategy and planning in several oncology indications, working cross-functionally with Clinical, Regulatory, and Commercial teams.
• Develop and refine frameworks for portfolio strategy, providing thought leadership and supporting key strategic and investment decisions.
• Deliver disease area strategy for new solid tumor indications by providing integrated strategy and market assessment in partnership with R&D, Clinical, Medical, Commercial, BD, and Program teams.

Qualifications:

• Bachelor's degree in Biotech or related field; advanced degree (MS, PhD) preferred.
• 12+ years of pharmaceuticals/biotech industry experience with qualitative and quantitative research in oncology/pharma market, with emphasis on NSCLC, colorectal cancer, and other solid tumors.
• Strong understanding of the solid tumor oncology landscape, including portfolio strategy, market planning, competitive intelligence, and forecasting.

Skills:

• Proven ability to identify and collect relevant market, customer, and competitor data; perform quantitative and qualitative analysis; and translate complex findings into actionable insights.
• Experience developing and executing primary and secondary market research, with exposure to global markets preferred.
• Skilled at PowerPoint, Excel, and similar data tools; ability to travel up to 30%.